Neural Regen Res, 2025 · DOI: https://doi.org/10.4103/NRR.NRR-D-24-00844 · Published: December 1, 2025
Spinal cord injury (SCI) disrupts nerve fibers and blood vessels, leading to loss of function. Traditional treatments have limitations and side effects. Emerging strategies use biomaterials, nanoparticles, and stem cells to promote regeneration and functional recovery. Ideal biomaterial scaffolds provide structural support, mimic spinal cord tissue, and facilitate axon growth. Three-dimensional bioprinting enhances the potential of biomaterials for SCI treatment. Nanoparticle-based systems deliver drugs and genes directly to the injury site, improving treatment effectiveness. Tissue engineering combines scaffolds with stem cells and growth factors to repair damaged tissues and minimize glial scars.
Nanodelivery systems can improve drug bioavailability and reduce side effects by delivering therapeutics directly to the injury site.
Biomaterial scaffolds combined with stem cells and growth factors can promote tissue repair and functional recovery after SCI.
3D bioprinting allows for the creation of customized scaffolds that can adapt to the specific needs of each patient.